{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:13:38Z","timestamp":1788315218138,"version":"build-2803163510"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T00:00:00Z","timestamp":1715299200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"JSPS KAKENHI","award":["23K07777"],"award-info":[{"award-number":["23K07777"]}]},{"name":"JSPS KAKENHI","award":["R03B-041"],"award-info":[{"award-number":["R03B-041"]}]},{"name":"JSPS KAKENHI","award":["R04B-048"],"award-info":[{"award-number":["R04B-048"]}]},{"name":"JSPS KAKENHI","award":["R05B-048"],"award-info":[{"award-number":["R05B-048"]}]},{"DOI":"10.13039\/501100009158","name":"Kawasaki Medical School","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009158","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Herpes zoster (HZ) rarely results in subsequent death, but predictive biomarkers for mortality necessitate further elucidation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To investigate immune dynamics prior to an HZ event, risk factors for HZ onset and immune status at initial HZ.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This retrospective study extracted from patient records the absolute neutrophil and lymphocyte counts (ANC and ALC, respectively) at the initial HZ date of appearance and up to 30 days before HZ. A follow-up survey was completed within 180 days of onset of illness.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Patients with HZ showed a higher neutrophil-to-lymphocyte ratio (NLR) and lower ALC than patients in the control group at the initial date and had a poorer prognosis. In the pre-onset examination, the maximum and minimum ALC values were significantly lower in patients with HZ than in the control group, and the maximum ALC value in patients with HZ was lower than the minimum value in the control group. The lowest ALC was observed 7 days before the onset of HZ. An NLR of 4.53 or more and an ALC of 0.64 \u00d7 109 cells L\u20131 or less were predictive markers of HZ development within 30 days. Patients who died after HZ had a lower minimum ALC than those who survived longer.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>HZ develops in a state of immune reconstitution in patients with immunocompromised conditions, as part of \u2018unmasking\u2019 the immune reconstitution inflammatory syndrome. Lymphopenia prior to HZ onset is one of the most crucial factors in its pathogenesis and vital prognosis. Limitations of the study were small population size, varying age distribution, retrospective nature, and potential overestimation of pre-onset data.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ced\/llae176","type":"journal-article","created":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T12:33:25Z","timestamp":1715258005000},"page":"1372-1378","source":"Crossref","is-referenced-by-count":3,"title":["Immune reconstitution is the trigger of herpes zoster with lymphopenia and high neutrophil-to-lymphocyte ratio in a retrospective cohort study"],"prefix":"10.1093","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7154-7033","authenticated-orcid":false,"given":"Takenobu","family":"Yamamoto","sequence":"first","affiliation":[{"name":"Department of Dermatology, Kawasaki Medical School , Kurashiki City, Okayama Prefecture ,","place":["Japan"]},{"name":"Department of Dermatology, Kawasaki Medical School General Medical Center , Kita-ku, Okayama City ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumi","family":"Aoyama","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Kawasaki Medical School , Kurashiki City, Okayama Prefecture ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,5,10]]},"reference":[{"key":"2024102416192322100_llae176-B1","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3390\/jcm8040547","article-title":"Does herpes zoster increase the risk of stroke and myocardial infarction? A comprehensive review","volume":"8","author":"Wu","year":"2019","journal-title":"J Clin Med"},{"key":"2024102416192322100_llae176-B2","doi-asserted-by":"crossref","first-page":"e004833","DOI":"10.1136\/bmjopen-2014-004833","article-title":"Systematic review of incidence and complications of herpes zoster: towards a global perspective","volume":"4","author":"Kawai","year":"2014","journal-title":"BMJ Open"},{"key":"2024102416192322100_llae176-B3","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1056\/NEJMp058091","article-title":"Aging, immunity, and the varicella-zoster virus","volume":"352","author":"Arvin","year":"2005","journal-title":"N Engl J Med"},{"key":"2024102416192322100_llae176-B4","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jdermsci.2012.10.015","article-title":"An inverse correlation of VZV skin-test reaction, but not antibody, with severity of herpes zoster skin symptoms and zoster-associated pain","volume":"69","author":"Asada","year":"2013","journal-title":"J Dermatol Sci"},{"issue":"Suppl. 1","key":"2024102416192322100_llae176-B5","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1086\/510206","article-title":"Recommendations for the management of herpes zoster","volume":"44","author":"Dworkin","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2024102416192322100_llae176-B6","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaa005","article-title":"Risk factors for herpes zoster infection: a meta-analysis","volume":"7","author":"Marra","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"2024102416192322100_llae176-B7","doi-asserted-by":"crossref","first-page":"e0255877","DOI":"10.1371\/journal.pone.0255877","article-title":"Herpes zoster epidemiology in Latin America: a systematic review and meta-analysis","volume":"16","author":"Bardach","year":"2021","journal-title":"PLOS ONE"},{"key":"2024102416192322100_llae176-B8","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1111\/jdv.18602","article-title":"Risk factor-specific mortality in herpes zoster in a retrospective cohort study: the neutrophil-to-\u00adlymphocyte ratio is a useful biomarker for predicting late-onset complications resulting in death","volume":"37","author":"Yamamoto","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2024102416192322100_llae176-B9","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/s41598-020-79431-7","article-title":"Neutrophil-to-lymphocyte ratio and mortality in the United States general population","volume":"11","author":"Song","year":"2021","journal-title":"Sci Rep"},{"key":"2024102416192322100_llae176-B10","doi-asserted-by":"crossref","first-page":"dju124","DOI":"10.1093\/jnci\/dju124","article-title":"Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis","volume":"106","author":"Templeton","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"2024102416192322100_llae176-B11","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/1346-8138.13875","article-title":"Neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and mean platelet volume in Japanese patients with psoriasis and psoriatic arthritis: response to therapy with biologics","volume":"44","author":"Asahina","year":"2017","journal-title":"J Dermatol"},{"key":"2024102416192322100_llae176-B12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.5505\/tjtes.2014.20688","article-title":"Neutrophil-to-lymphocyte ratio as a predictor of acute appendicitis","volume":"20","author":"Kahramanca","year":"2014","journal-title":"Ulus Travma Acil Cerrahi Derg"},{"key":"2024102416192322100_llae176-B13","author":"e-Stat Portal Site of Official Statistics of Japan"},{"key":"2024102416192322100_llae176-B14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13104-016-2335-5","article-title":"What is the normal value of the neutrophil-to-lymphocyte ratio?","volume":"10","author":"Forget","year":"2017","journal-title":"BMC Res Notes"},{"key":"2024102416192322100_llae176-B15","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1001\/jama.280.1.72","article-title":"Recovery of the immune system with antiretroviral therapy: the end of opportunism?","volume":"280","author":"Powderly","year":"1998","journal-title":"JAMA"},{"key":"2024102416192322100_llae176-B16","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1086\/630208","article-title":"Defining immune reconstitution inflammatory syndrome: evaluation of expert opinion versus 2 case definitions in a South African cohort","volume":"49","author":"Haddow","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2024102416192322100_llae176-B17","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2332\/allergolint.10-RAI-0260","article-title":"Recognition of immune reconstitution syndrome necessary for better management of patients with severe drug eruptions and those under immunosuppressive therapy","volume":"59","author":"Shiohara","year":"2010","journal-title":"Allergol Int"},{"key":"2024102416192322100_llae176-B18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/1346-8138.14074","article-title":"Immune reconstitution inflammatory syndrome in non-HIV immunosuppressed patients","volume":"45","author":"Sueki","year":"2018","journal-title":"J\u00a0Dermatol"},{"key":"2024102416192322100_llae176-B19","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0042-6822(84)90263-0","article-title":"Simian varicella virus DNA shares homology\u00a0with human varicella-zoster virus DNA","volume":"136","author":"Gray","year":"1984","journal-title":"Virology"},{"key":"2024102416192322100_llae176-B20","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/0042-6822(92)90022-H","article-title":"The simian varicella virus and varicella zoster virus genomes are similar in size and structure","volume":"186","author":"Gray","year":"1992","journal-title":"Virology"},{"key":"2024102416192322100_llae176-B21","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0168-1702(92)90017-4","article-title":"The genomes of simian varicella virus\u00a0and varicella zoster virus are colinear","volume":"26","author":"Pumphrey","year":"1992","journal-title":"Virus Res"},{"key":"2024102416192322100_llae176-B22","doi-asserted-by":"crossref","first-page":"9817","DOI":"10.1128\/JVI.01324-15","article-title":"Simian varicella virus is present in macrophages, dendritic cells and T cells in lymph nodes of rhesus macaques after experimental reactivation","volume":"89","author":"Traina-Dorge","year":"2015","journal-title":"J Virol"},{"key":"2024102416192322100_llae176-B23","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s13365-014-0237-7","article-title":"T cells increase before zoster and PD-1 expression increases at the time of zoster in immunosuppressed nonhuman primates latently infected with simian varicella virus","volume":"20","author":"James","year":"2014","journal-title":"J Neurovirol"},{"key":"2024102416192322100_llae176-B24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s40425-019-0549-5","article-title":"Lymphopenia in cancer patients and its effects on response to immunotherapy: an opportunity for combination with cytokines?","volume":"7","author":"M\u00e9n\u00e9trier-Caux","year":"2019","journal-title":"J Immunother Cancer"},{"key":"2024102416192322100_llae176-B25","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"2024102416192322100_llae176-B26","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1038\/s41418-021-00817-9","article-title":"Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis","volume":"28","author":"Goubet","year":"2021","journal-title":"Cell Death Differ"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llae176\/58616147\/llae176.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/49\/11\/1372\/60035436\/llae176.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/49\/11\/1372\/60035436\/llae176.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T16:19:45Z","timestamp":1729786785000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/49\/11\/1372\/7667912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,10]]},"references-count":26,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,5,10]]},"published-print":{"date-parts":[[2024,10,24]]}},"URL":"https:\/\/doi.org\/10.1093\/ced\/llae176","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,11]]},"published":{"date-parts":[[2024,5,10]]}}}